Cutaneous Melioidosis in the Tropical Top End of Australia: a Prospective Study and Review of the Literature
Overview
Affiliations
Background: Burkholderia pseudomallei is endemic in northern Australia, and melioidosis is a common cause of sepsis in the region.
Methods: We summarized the cutaneous manifestations of melioidosis from a prospective cohort of 486 patients with culture-confirmed melioidosis in northern Australia, and we compared those who had primary skin melioidosis with those who had other forms of melioidosis.
Results: Primary skin melioidosis occurred in 58 patients (12%). Secondary skin melioidosis--multiple pustules from hematogenous spread--was present in 10 patients (2%). Patients with primary skin melioidosis were more likely to have chronic presentations (duration, >or=2 months). On multivariate analysis, patients with primary cutaneous melioidosis were more likely to be children aged <or=15 years (adjusted odds ratio, 8.50; 95% confidence interval [CI], 3.24-22.28) and to have a history of occupational exposure to B. pseudomallei (adjusted odds ratio, 3.12; 95% CI, 1.56-6.25) but were less likely to have typical risk factors--including diabetes (adjusted odds ratio, 0.26; 95% CI, 0.12-0.56), excessive alcohol intake (adjusted odds ratio, 0.45; 95% CI, 0.22-0.90), and chronic lung disease (adjusted odds ratio, 0.26; 95% CI, 0.10-0.67). Of those patients with primary skin melioidosis, 1 patient was bacteremic and none had severe sepsis or died from melioidosis. Four (7%) of the 58 patients presenting with primary skin melioidosis had disseminated melioidosis, and 1 (2%) experienced a relapse of melioidosis. Nine patients (16%) were cured with a regimen of oral antibiotics alone, and 1 recovered with no therapy.
Conclusion: In our cohort, patients with primary skin melioidosis were younger, had fewer underlying medical conditions, and had better outcomes than did those with other forms of melioidosis. There may be a role for exclusive oral antibiotic therapy for some cases of primary skin melioidosis.
Whitmore's Disease: A Case Report of Melioidosis Triggering Hemophagocytic Lymphohistiocytosis.
Bojanapati K, Gohil R, Siddem C, Kumar J Cureus. 2024; 16(8):e65948.
PMID: 39221302 PMC: 11365461. DOI: 10.7759/cureus.65948.
Ni H, Zhang Y, Huang D, Zhou F World J Clin Cases. 2024; 12(9):1669-1676.
PMID: 38576731 PMC: 10989420. DOI: 10.12998/wjcc.v12.i9.1669.
Clinical Profile and Predictors of Mortality among Patients with Melioidosis.
Raj S, Sistla S, Sadanandan D, Kadhiravan T, Rameesh B, Amalnath D J Glob Infect Dis. 2023; 15(2):72-78.
PMID: 37469465 PMC: 10353644. DOI: 10.4103/jgid.jgid_134_22.
Case report long segment myelitis secondary to neuro melioidosis.
Vithoosan S, Kumarasiri A, Vithanage N, Senanayake B BMC Neurol. 2022; 22(1):387.
PMID: 36261785 PMC: 9580144. DOI: 10.1186/s12883-022-02917-6.
Melioidosis in the remote Katherine region of northern Australia.
Hodgetts K, Kleinecke M, Woerle C, Kaestli M, Budd R, Webb J PLoS Negl Trop Dis. 2022; 16(6):e0010486.
PMID: 35696415 PMC: 9232150. DOI: 10.1371/journal.pntd.0010486.